Does Managing Patients With Chronic Rhinosinusitis Improve Their Depression Score? Prospective Study

Uloženo v:
Podrobná bibliografie
Název: Does Managing Patients With Chronic Rhinosinusitis Improve Their Depression Score? Prospective Study
Autoři: Almofada, Hesham Saleh, Almutairi, Nasser, Aldakhil, Haifa, Alokby, Ghassan
Zdroj: J Otolaryngol Head Neck Surg
Informace o vydavateli: SAGE Publications, 2024.
Rok vydání: 2024
Témata: Male, Adult, Depression, Rhinosinusitis, Saudi Arabia, Middle Aged, Female [MeSH], Rhinitis/therapy [MeSH], Adult [MeSH], Humans [MeSH], Prospective Studies [MeSH], Sinusitis/therapy [MeSH], Middle Aged [MeSH], Sinusitis/psychology [MeSH], depression, chronic rhinosinusitis, Sino-Nasal Outcome Test [MeSH], Rhinitis/psychology [MeSH], Male [MeSH], Depression/diagnosis [MeSH], Chronic Disease [MeSH], Sinusitis/complications [MeSH], Rhinosinusitis [MeSH], Rhinitis/complications [MeSH], Sinonasal Outcome Test, Patient Health Questionnaire-9, Original Research Article, Depression/etiology [MeSH], Saudi Arabia [MeSH], 03 medical and health sciences, 0302 clinical medicine, Chronic Disease, Humans, Female, Sino-Nasal Outcome Test, Prospective Studies, Sinusitis, Rhinitis
Popis: Background To assess the risk of depression in patients with chronic rhinosinusitis (CRS) in a tertiary care center and the effect of treatment on depression scores. Methods This prospective cohort study was conducted at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia, between November 2021 and June 2022 and included adult patients (≥14 years) with CRS. The validated Arabic or English Sinonasal Outcome Test (SNOT-22) and Patient Health Questionnaire-9 (PHQ-9) were used before treatment and 3 to 6 months after surgery and maximal medical treatment. PHQ-9 scores were compared at baseline and follow-up visits. The relationship between changes in SNOT-22 and PHQ-9 scores were assessed using Spearman’s correlation and simple linear regression. Results Overall, 38 participants with a mean ± SD age of 32.7 ± 12 years were enrolled. CRS with nasal polyps (55.26%) was the most frequently seen condition, followed by allergic fungal CRS (31.58%) and CRS without nasal polyps (13.16%). Six patients (15.7%) had PHQ-9 scores ≥10, indicating they had major depressive disorder. PHQ-9 and SNOT-22 scores improved significantly after treatment (3.7 ± 5.8 vs 6.5 ± 6.9 pretreatment, P = .001; 20.7 ± 20.5 vs 45.6 ± 28.9 pretreatment, P Conclusion CRS affects the quality of life and psychological well-being of patients. Patient-centered care with maximal medical and surgical treatment help overcome its deleterious consequences.
Druh dokumentu: Article
Other literature type
Jazyk: English
ISSN: 1916-0216
DOI: 10.1177/19160216241248668
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38888948
https://repository.publisso.de/resource/frl:6484615
Rights: CC BY NC
Přístupové číslo: edsair.doi.dedup.....21c83e2afd52b0bddb0d471f018099ec
Databáze: OpenAIRE
Popis
Abstrakt:Background To assess the risk of depression in patients with chronic rhinosinusitis (CRS) in a tertiary care center and the effect of treatment on depression scores. Methods This prospective cohort study was conducted at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia, between November 2021 and June 2022 and included adult patients (≥14 years) with CRS. The validated Arabic or English Sinonasal Outcome Test (SNOT-22) and Patient Health Questionnaire-9 (PHQ-9) were used before treatment and 3 to 6 months after surgery and maximal medical treatment. PHQ-9 scores were compared at baseline and follow-up visits. The relationship between changes in SNOT-22 and PHQ-9 scores were assessed using Spearman’s correlation and simple linear regression. Results Overall, 38 participants with a mean ± SD age of 32.7 ± 12 years were enrolled. CRS with nasal polyps (55.26%) was the most frequently seen condition, followed by allergic fungal CRS (31.58%) and CRS without nasal polyps (13.16%). Six patients (15.7%) had PHQ-9 scores ≥10, indicating they had major depressive disorder. PHQ-9 and SNOT-22 scores improved significantly after treatment (3.7 ± 5.8 vs 6.5 ± 6.9 pretreatment, P = .001; 20.7 ± 20.5 vs 45.6 ± 28.9 pretreatment, P Conclusion CRS affects the quality of life and psychological well-being of patients. Patient-centered care with maximal medical and surgical treatment help overcome its deleterious consequences.
ISSN:19160216
DOI:10.1177/19160216241248668